XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.95%7.43B | -6.30%1.8B | -8.02%1.87B | -9.23%1.88B | -11.93%1.88B | 2.69%8.16B | -3.32%1.92B | 0.49%2.03B | 1.22%2.07B | 12.95%2.14B |
Operating revenue | -8.95%7.43B | -6.30%1.8B | -8.02%1.87B | -9.23%1.88B | -11.93%1.88B | 2.69%8.16B | -3.32%1.92B | 0.49%2.03B | 1.22%2.07B | 12.95%2.14B |
Cost of revenue | -12.04%5.64B | -11.18%1.35B | -13.71%1.39B | -12.04%1.43B | -11.21%1.47B | -0.64%6.41B | -7.03%1.52B | -2.24%1.61B | -1.57%1.63B | 9.05%1.65B |
Gross profit | 2.40%1.79B | 12.25%449M | 13.78%479M | 1.13%446M | -14.37%417M | 17.07%1.75B | 13.96%400M | 12.57%421M | 13.08%441M | 28.50%487M |
Operating expense | 0.00%781M | 0.51%198M | 0.51%199M | -3.68%183M | 2.55%201M | 7.28%781M | 0.51%197M | 4.21%198M | 8.57%190M | 17.37%196M |
Other operating expenses | 0.00%781M | 0.51%198M | 0.51%199M | -3.68%183M | 2.55%201M | 7.28%781M | 0.51%197M | 4.21%198M | 8.57%190M | 17.37%196M |
Operating profit | 4.34%1.01B | 23.65%251M | 25.56%280M | 4.78%263M | -25.77%216M | 26.37%968M | 30.97%203M | 21.20%223M | 16.74%251M | 37.26%291M |
Net non-operating interest income expense | 65.79%-39M | 65.38%-9M | 96.15%-1M | 66.67%-10M | 40.63%-19M | -15.15%-114M | 23.53%-26M | -8.33%-26M | -76.47%-30M | -33.33%-32M |
Non-operating interest expense | -65.79%39M | -65.38%9M | -96.15%1M | -66.67%10M | -40.63%19M | 15.15%114M | -23.53%26M | 8.33%26M | 76.47%30M | 33.33%32M |
Other net income (expense) | -166.67%-40M | -8,900.00%-90M | 50.00%-6M | -1,050.00%-23M | 79M | -1,600.00%-15M | -133.33%-1M | -1,300.00%-12M | 0.00%-2M | |
Special income (charges) | -236.36%-37M | -8,800.00%-89M | 60.00%-4M | ---23M | --79M | -175.00%-11M | -150.00%-1M | -400.00%-10M | --0 | --0 |
-Less:Restructuring and merger&acquisition | 1,054.55%127M | 8,800.00%89M | 20.00%12M | --23M | --3M | 175.00%11M | 150.00%1M | 400.00%10M | --0 | --0 |
-Gain on sale of business | --90M | --0 | --8M | --0 | --82M | ---- | ---- | --0 | --0 | --0 |
Other non- operating income (expenses) | 25.00%-3M | ---1M | 0.00%-2M | ---- | ---- | -180.00%-4M | --0 | -166.67%-2M | ---2M | ---- |
Income before tax | 10.97%931M | -13.64%152M | 47.57%273M | 5.02%230M | 6.56%276M | 25.60%839M | 41.94%176M | 14.91%185M | 11.73%219M | 38.50%259M |
Income tax | 47.34%277M | 27.91%55M | 236.00%84M | 45.45%80M | -10.77%58M | 13.25%188M | 377.78%43M | -51.92%25M | 7.84%55M | 20.37%65M |
Net income | 0.46%654M | -27.07%97M | 18.13%189M | -8.54%150M | 12.37%218M | 29.68%651M | 15.65%133M | 46.79%160M | 13.10%164M | 45.86%194M |
Net income continuous Operations | 0.46%654M | -27.07%97M | 18.13%189M | -8.54%150M | 12.37%218M | 29.68%651M | 15.65%133M | 46.79%160M | 13.10%164M | 45.86%194M |
Minority interest income | -12.50%7M | 0.00%2M | -50.00%1M | 100.00%2M | -33.33%2M | -20.00%8M | 100.00%2M | -33.33%2M | -66.67%1M | 0.00%3M |
Net income attributable to the parent company | 0.62%647M | -27.48%95M | 18.99%188M | -9.20%148M | 13.09%216M | 30.69%643M | 14.91%131M | 49.06%158M | 14.79%163M | 46.92%191M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 0.62%647M | -27.48%95M | 18.99%188M | -9.20%148M | 13.09%216M | 30.69%643M | 14.91%131M | 49.06%158M | 14.79%163M | 46.92%191M |
Basic earnings per share | 1.44%9.88 | -27.00%1.46 | 20.50%2.88 | -8.54%2.25 | 13.84%3.29 | 31.09%9.74 | 15.61%2 | 48.45%2.39 | 14.95%2.46 | 48.97%2.89 |
Diluted earnings per share | 1.15%9.71 | -27.41%1.43 | 19.92%2.83 | -8.26%2.22 | 13.33%3.23 | 30.79%9.6 | 15.20%1.97 | 48.43%2.36 | 14.15%2.42 | 48.44%2.85 |
Dividend per share | 6.04%3.16 | 2.56%0.8 | 2.56%0.8 | 9.86%0.78 | 9.86%0.78 | 9.56%2.98 | 9.86%0.78 | 9.86%0.78 | 9.23%0.71 | 9.23%0.71 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |